Floatz logo

Photofrin II

Lung Metastasis

Taoyuan General HospitalmixturePhase 1Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Lung Metastasis cohort.

Asset / SponsorPhaseRating
MITOMYCIN C
Seoul National University Hospital
Phase 2CCC
FLUOROURACILUM
Seoul National University Hospital
Phase 2CCC
bmd006
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1C
Ethiodized Oil
Taoyuan General Hospital
Early Phase 1C

Same molecule, other indications

Photofrin II is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
63 / 100
View asset →
central nervous system neoplasmDormant
B
Indicative ·
62 / 100
View asset →
extrahepatic bile duct carcinomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →